Clinical effect analysis of unilateral biportal endoscopic transforaminal lumbar interbody fusion in the treatment of lumbar spinal stenosis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200065499

Enrollment

Unknown

Registered

2022-11-07

Start date

2022-11-20

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spinal stenosis

Interventions

UBE group:unilateral biportal endoscopic transforaminal lumbar interbody fusion

Control group:posterior lumbar interbody fusion

Eligibility

Sex/Gender

All

Age

60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Elderly patients aged 60-85 years; 2. Single stage lumbar spinal stenosis; 3. Follow-up showed no loss.

Exclusion criteria

Exclusion criteria: 1. Severe lumbar spondylolisthesis; 2. Vertebral fracture; 3. Lumbar metastatic tumor; 4. Lumbar tuberculosis.

Design outcomes

Primary

Measure	Time frame
Operation time;Intraoperative blood loss;Postoperative hospitalization days;Surgical incision length;Postoperative complications;Patient's Oswestry Disability Index (ODI) score;Patient's Visual Analogue Scale (VAS) score;	—

Countries

China

Contacts

Public ContactXiao Ouyang

Xuzhou Cancer Hospital

2543094095@qq.com+86 15162100079

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026